FdaApplication
NDA 208065
Identifiers
- fda_app_no: NDA208065
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA PHARMACEUTICALS LP |
| application_type | NDA |
| approval_date | 2015-11-13 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAGRISSO | OSIMERTINIB MESYLATE | EQ 40MG BASE | TABLET;ORAL |
| TAGRISSO | OSIMERTINIB MESYLATE | EQ 80MG BASE | TABLET;ORAL |
2 products